Clin2
NCT07665476Possibly a fitNot yet recruiting

Naproxen vs placebo for cellulitis treatment

CellulitisSkin Disease, InfectiousInfectionSkin and Soft Tissue Infections (SSTIs)

Treatments studied

Part of Infections, Skin clinical trials.

This trial tests whether adding naproxen (a common pain and inflammation medicine) to standard antibiotic treatment helps people with cellulitis recover faster. You may be eligible if you have cellulitis and your doctor says you can take oral antibiotics at home.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
884 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older.
  • You have cellulitis and your doctor says you can be treated at home with the antibiotic cephalexin.
  • You are not already taking antibiotics or NSAIDs (like ibuprofen or naproxen).
  • You have not had an allergic reaction to NSAIDs, aspirin, or penicillins.
  • You are not pregnant or breastfeeding.
  • You have no medical history that prevents safe use of naproxen, such as kidney problems, stomach ulcers, or certain heart conditions.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06715306Recruiting
IV vs. Oral Antibiotics for Common Infections

This trial compares starting antibiotics through a vein (IV) to taking them by mouth for common infections like pneumonia, urinary tract infections, or skin infections (cellulitis). The goal is to see if oral antibiotics work just as well without the need for an IV line.

Aabenraa, Southern Denmark
NCT05584007Recruiting· Phase 3
Choosing the best antibiotic length for leg cellulitis

This Phase 3 study compares 5 days versus 7 days of antibiotic treatment for new leg cellulitis (skin infection). It may help you get the right treatment duration while keeping side effects and recovery in mind.

Southampton
NCT07104552Not yet recruiting· Phase 4
Shorter vs standard antibiotics for erysipelas

This trial compares a short course of amoxicillin (5 days) to the standard longer course (10 days) for erysipelas, a skin infection of the lower legs. It aims to see if the shorter treatment works just as well, with fewer side effects.

NCT07549594Not yet recruiting· Phase 4
Compression therapy versus antibiotics for recurrent leg infections

This study compares two ways to prevent erysipelas (a painful skin infection) from coming back on your leg: wearing compression stockings alone, or taking antibiotics plus wearing compression stockings. Researchers want to see which approach works better and is safer long-term.

Amiens
NCT05851976Recruiting· Phase 4
Duloxetine for short-term non-radiating low back pain

This trial tests duloxetine (a medicine used for certain pain conditions and mood) for easing low back pain that started recently and doesn’t shoot down your leg. It may help reduce pain and improve daily function after an ER visit, but you must meet several safety and medication-use criteria.

The Bronx, New York
NCT04538053Recruiting· Phase 4
Simpler antibiotics for uncomplicated bone and joint infections in children

This trial looks at whether a simpler antibiotic plan can work for children with uncomplicated bone or joint infections that start in the community. It may help reduce the need for complicated treatment while still keeping the infection under control.

Kingswood, New South Wales

Hear when a new Cellulitis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.